Page last updated: 2024-11-05

1,3-xylenediamine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

1,3-Xylenediamine, also known as m-xylenediamine, is a colorless to pale yellow liquid with a characteristic amine odor. It is a versatile chemical intermediate used in the production of various polymers, resins, and pharmaceuticals. The compound can be synthesized through the hydrogenation of 1,3-dinitrobenzene or by the reaction of m-xylene with nitric acid followed by reduction. 1,3-Xylenediamine exhibits a high degree of reactivity due to the presence of two amino groups, making it a valuable building block in organic synthesis. It is also known to possess antibacterial and antifungal properties, attracting research interest in its potential applications in the pharmaceutical and agricultural industries. '

1,3-xylenediamine: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID15133
CHEMBL ID384146
SCHEMBL ID36008
MeSH IDM0183503

Synonyms (71)

Synonym
LS-13448
nsc61568
m-diaminoxylene
mxda
nsc-61568
m-xylylene amine
.alpha.,.alpha.'-diamino-m-xylene
1,3-bis(aminomethyl)benzene
1,3-bis-aminomethylbenzen
m-xylylenediamine
.alpha.,.alpha.'-m-xylenediamine
m-phenylenebis(methylamine)
1477-55-0
m-xylylendiamin
m-xylene-.alpha.,.alpha.'-diamine
methylamine, m-phenylenebis-
1,3-benzenedimethanamine
1,3-xylylenediamine
alpha,alpha'-diamino-m-xylene
ai3-25033
einecs 216-032-5
1,3-xylenediamine
1,3-bis-aminomethylbenzen [czech]
ccris 6681
m-xylene-alpha,alpha'-diamine
m-xylylendiamin [czech]
brn 1099911
nsc 61568
hsdb 6257
fdlqzkylhjjbhd-uhfffaoysa-
inchi=1/c8h12n2/c9-5-7-2-1-3-8(4-7)6-10/h1-4h,5-6,9-10h2
m-xylylenediamine, 99%
1,3-phenylenedimethanamine
AC-11133
m-xylene diamine
3-(aminomethyl)benzylamine
(3-(aminomethyl)phenyl)methanamine
CHEMBL384146
[3-(aminomethyl)phenyl]methanamine
AKOS000119451
NCGC00248826-01
1e84b9yljd ,
ec 216-032-5
unii-1e84b9yljd
cas-1477-55-0
NCGC00257445-01
tox21_303362
dtxsid9029649 ,
dtxcid909649
NCGC00258320-01
tox21_200766
FT-0629046
xylenediamine, m-
1,3-benzenedimethanamine [hsdb]
SCHEMBL36008
aminomethyl-3-aminomethylbenzene
metaxylylenediamine
m-xylylene diamine
metaxylylene diamine
m-(aminomethyl)benzylamine
epilink mx
3-(aminomethyl)benzylamine #
Q-200398
mfcd00008119
m-xylylenediamine, purum, >=98.0% (nt)
3-aminomethyl-benzylamine
Q15726051
EN300-20441
1,3-benzenebis(methylamine) 100 microg/ml in acetonitrile
1,3-benzenebis(methylamine)
F71376
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (6)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
acetylcholinesteraseHomo sapiens (human)Potency88.00110.002541.796015,848.9004AID1347395; AID1347398
retinoic acid nuclear receptor alpha variant 1Homo sapiens (human)Potency29.74770.003041.611522,387.1992AID1159552; AID1159555
pregnane X nuclear receptorHomo sapiens (human)Potency73.71800.005428.02631,258.9301AID1346982
estrogen nuclear receptor alphaHomo sapiens (human)Potency33.40670.000229.305416,493.5996AID743075; AID743080
aryl hydrocarbon receptorHomo sapiens (human)Potency62.81290.000723.06741,258.9301AID743085; AID743122
thyroid hormone receptor beta isoform 2Rattus norvegicus (Norway rat)Potency59.24180.000323.4451159.6830AID743065
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (2)

Assay IDTitleYearJournalArticle
AID273097Activity of human SSAO measured as hydrogen peroxide production at 1 mM relative to benzylamine oxidation2006Journal of medicinal chemistry, Oct-19, Volume: 49, Issue:21
New efficient substrates for semicarbazide-sensitive amine oxidase/VAP-1 enzyme: analysis by SARs and computational docking.
AID273098Activity of mouse SSAO measured as hydrogen peroxide production at 100 uM relative to benzylamine oxidation2006Journal of medicinal chemistry, Oct-19, Volume: 49, Issue:21
New efficient substrates for semicarbazide-sensitive amine oxidase/VAP-1 enzyme: analysis by SARs and computational docking.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (14)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (7.14)18.7374
1990's1 (7.14)18.2507
2000's6 (42.86)29.6817
2010's6 (42.86)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.95

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.95 (24.57)
Research Supply Index2.94 (2.92)
Research Growth Index4.90 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.95)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (5.88%)5.53%
Reviews0 (0.00%)6.00%
Case Studies2 (11.76%)4.05%
Observational0 (0.00%)0.25%
Other14 (82.35%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]